Gjin Ndrepepa

Showing 1-14 of 14 articles

Coronary interventions

Clinical and Angiographic Outcomes of Crossing Techniques for Coronary Chronic Total Occlusions - The ISAR-CTO Registry

Xhepa E, Cassese S, Ndrepepa G, Joner M, Kufner S, Aytekin A, Lahmann AL, Voll F, Fusaro M, Pinieck S, Schunkert H, Kastrati A, Fusaro M

March 2, 2021 | 10.4244/EIJ-D-20-01248

Coronary interventions

Clinical outcomes by optical characteristics of neointima and treatment modality in patients with coronary in-stent restenosis

Xhepa E, Bresha J, Joner M, Hapfelmeier A, Rivero F, Ndrepepa G, Nano N, Cuesta J, Kufner S, Cassese S, Bastante T, Aytekin A, Rroku A, Garcia Guimaraes M, Lahmann AL, Pinieck S, Rai H, Fusaro M, Schunkert H, Perez Vizcayno MJ, Gonzalo N, Alfonso F, Kastrati A

September 8, 2020 | 10.4244/EIJ-D-20-00662

Obesity paradox after percutaneous coronary intervention - closing in on the truth behind the phenomenon

Ndrepepa G, Kastrati A

January 17, 2020 | 10.4244/EIJV15I13A208

Peripheral interventions

Paclitaxel density and clinical efficacy of drug-coated balloon angioplasty for femoropopliteal artery disease: meta-analysis and adjusted indirect comparison of 20 randomised trials

Cassese S, Ndrepepa G, Fusaro M, Kufner S, Xhepa E, Fusaro M

August 9, 2019 | 10.4244/EIJ-D-18-00550

No-reflow after percutaneous coronary intervention: a correlate of poor outcome in both persistent and transient forms

Ndrepepa G, Colleran R, Kastrati A

June 20, 2018 | 10.4244/EIJV14I2A21

Coronary interventions

Outcomes of patients treated with ultrathin-strut biodegradable polymer sirolimus-eluting stents versus fluoropolymer-based everolimus-eluting stents: a meta-analysis of randomised trials

Cassese S, Ndrepepa G, Byrne R, Kufner S, Lahmann AL, Mankerious N, Xhepa E, Laugwitz K, Schunkert H, Fusaro M, Kastrati A, Joner M

June 20, 2018 | 10.4244/EIJ-D-18-00024

Midterm clinical outcomes with everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents for percutaneous coronary interventions: a meta-analysis of randomised trials

Cassese S, Byrne R, Jüni P, Wykrzykowska J, Puricel S, Ndrepepa G, Schunkert H, Fusaro M, Cook S, Kimura T, Henriques J, Serruys P, Windecker S, Kastrati A

January 19, 2018 | 10.4244/EIJ-D-17-00492

Outcomes of patients treated with durable polymer platinum-chromium everolimus-eluting stents: a meta-analysis of randomised trials

Cassese S, Ndrepepa G, Byrne R, Kufner S, Xhepa E, De Waha A, Rheude T, Colleran R, Giacoppo D, Harada Y, Laugwitz K, Schunkert H, Fusaro M, Kastrati A

October 20, 2017 | 10.4244/EIJ-D-16-00871

Peripheral interventions

Drug-coated balloon angioplasty for in-stent restenosis of femoropopliteal arteries: a meta-analysis

Cassese S, Ndrepepa G, Kufner S, Byrne R, Giacoppo D, Ott I, Laugwitz K, Schunkert H, Kastrati A, Fusaro M

July 20, 2017 | 10.4244/EIJ-D-16-00735

Coronary interventions

Mechanical strategies to enhance myocardial salvage during primary percutaneous coronary intervention in patients with STEMI

Ndrepepa G, Kastrati A

June 20, 2016 | 10.4244/EIJV12I3A52

Coronary interventions

Impact of bivalirudin on post-procedural epicardial blood flow, risk of stent thrombosis and mortality after percutaneous coronary intervention

Fiedler A, Ndrepepa G, Schulz S, Floh S, Hoppmann P, Kufner S, Bernlochner I, Byrne R, Schunkert H, Laugwitz K, Kastrati A

February 12, 2016 | 10.4244/EIJV11I11A249

Proximal occlusion versus distal filter for cerebral protection during carotid stenting: updated meta-analysis of randomised and observational MRI studies

Cassese S, Ndrepepa G, King L, Nerad M, Schunkert H, Kastrati A, Ott I, Fusaro M

June 19, 2015 | 10.4244/EIJY15M03_01

Prognostic value of bleeding after percutaneous coronary intervention in patients with diabetes

Ndrepepa G, Schulz S, Neumann F, Laugwitz K, Richardt G, Byrne R, Pohler A, Kastrati A, Pache J

May 20, 2014 | 10.4244/EIJV10I1A14

Impact of perfusion restoration at epicardial and tissue levels on markers of myocardial necrosis and clinical outcome of patients with acute myocardial infarction

Ndrepepa G, Alger P, Fusaro M, Kufner S, Seyfarth M, Keta D, Mehilli J, Schömig A, Kastrati A

May 17, 2011 | 10.4244/EIJV7I1A21

Latest news

NEW ISSUE

Infective Endocarditis & TAVI; Cerebral Protection Devices; IVUS Assessment in ViV-TAVI, Mini Focus on Antithrombotic Therapy …

February 19, 2021

News

Don’t Miss #EIJOnAir 2nd Edition!

Elective cardiac invasive procedures during the COVID-19 outbreak

March 4, 2021

Ahead of Print

MitraClip for a range of LV dysfunction and secondary MR

Stamatios Lerakis et al.

March 2, 2021

Editorial

Thrombolysis in ST-elevation myocardial infarction is not dead

Petr Kala et al.

March 2, 2021

SCOPE 2, COACT 1 year, FORZA, COMPARE CRUSH

(Thanks to the support of Biotronik)

February 28, 2021

JAA

This Week's JAA's: Impact of crossing strategy on CTO recanalisation outcomes and more...

March 2, 2021

Guidance Papers

Guidelines, consensus & position papers